0.446
Gelteq Ltd Aktie (GELS) Neueste Nachrichten
Gelteq Limited Ordinary Shares (NASDAQ: GELS) Share Price, GELS Stock News, GELS Share Price & Updates - kalkine.ca
Gelteq Limited Ordinary Shares (NASDAQ: GELS) Share Price, GELS Stock News, GELS Share Price & Updates - kalkine.com.au
GELS: Gelteq Ltd. Latest Stock Price, Analysis, News and Trading Ideas - stocktwits.com
Nasdaq Gains Over 200 Points; US Weekly Jobless Claims Edge Higher - benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Gelteq Ltd (GELS) Earnings Date & Reports & Earnings News - TradingKey
Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GELS|Gelteq Ltd|Price:0.670|Chg%:-0.031 - TradingKey
Gelteq Ltd (GELS) Balance Sheet - TradingKey
Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Gelteq Ltd (GELS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Gelteq Ltd (GELS) Cash Flow - TradingKey
Gelteq Ltd (GELS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Gelteq Ltd (GELS) Institutional Confidence - TradingKey
Gelteq Ltd (GELS) Income Statement - TradingKey
GELS|Gelteq Ltd|Price:0.701|Chg%:-0.042 - TradingKey
Gelteq Limited (GELS) Surges 9.39%, Approaching Key Resistance at $0.78Value ETF - dars.gov.et
Gelteq | 3: Initial statement of beneficial ownership of securities- Givoni Nathan J - Moomoo
Gelteq | 3: Initial statement of beneficial ownership of securities- Karp Bradley Glenn - Moomoo
Gelteq (GELS) wins shareholder approval and closes $2.5M second tranche note - Stock Titan
GELSGelteq Ltd Short Interest - Finviz
GELSGelteq Ltd Latest SEC Filings - Finviz
Gelteq (GELS) faces $5.3M working capital deficit and rising debt - Stock Titan
Gelteq Company Profile & Introduction - Moomoo
Gelteq Ltd (GELS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Gelteq Ltd (GELS) Institutional Confidence - TradingKey
Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Gelteq advances clinical programs across pharmaceutical and veterinary applications By Investing.com - Investing.com India
Gelteq advances clinical programs across pharmaceutical and veterinary applications By Investing.com - Investing.com Australia
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - The Manila Times
Gelteq lines up first human trial, vet study and $3.5M financing - Stock Titan
Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Gelteq advances clinical programs across pharmaceutical and veterinary applications - Investing.com
Gelteq Ltd (GELS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
$Gelteq (GELS.US)$ thank you - Moomoo
GELSGelteq Ltd Earnings - Finviz
What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times
Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):